Presymptomatic testing for neurogenetic diseases in Brazil: assessing who seeks and who follows through with testing.
about
Bioethical issues of preventing hereditary diseases with late onset in the Sakha Republic (Yakutia)Predictive testing for inherited prion disease: report of 22 years experience.SCA2 predictive testing in Cuba: challenging concepts and protocol evolution.Neurogenetics in Peru: clinical, scientific and ethical perspectives.Quality issues concerning genetic counselling for presymptomatic testing: a European Delphi studyCouples at risk for spinocerebellar ataxia type 2: the Cuban prenatal diagnosis experience.Genetic counseling and presymptomatic testing programs for Machado-Joseph Disease: lessons from Brazil and Portugal.Nonmotor and extracerebellar features in Machado-Joseph disease: a review.Illness representations, knowledge and motivation to perform presymptomatic testing for late-onset genetic diseases.The Cuban program for predictive testing of SCA2: 11 years and 768 individuals to learn from.Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3.1993-2014: two decades of predictive testing for Huntington's disease at the Medical Genetics Unit of the University of GenoaFollow-up nationwide survey on predictive genetic testing for late-onset hereditary neurological diseases in Japan.Genetics Health Professionals' Views on Quality of Genetic Counseling Service Provision for Presymptomatic Testing in Late-Onset Neurological Diseases in Portugal: Core Components, Specific Challenges and the Need for Assessment Tools.
P2860
Q28655316-87810391-B5BE-48F3-881C-DB607B603720Q33882164-CECB8E8C-CCDE-414F-B4B0-EDA2F0E9FA30Q35915980-43630C72-2B88-451C-8F42-940E4D967D22Q35916127-903C8A19-1B1F-416B-ADF3-81C4E9894905Q36184538-CBA134C9-F781-487C-A244-210236466469Q37171569-46E14307-0C5C-4D3B-BFC5-9232A1CC4794Q37697809-6A366F1A-DD6C-48BD-8D76-288CAFA44B4BQ38115268-B02E7750-0EE6-4F94-85DF-F1339B73C726Q38899295-242E727A-9670-445A-B479-1EE7F3520406Q39451102-DBE46613-C914-4D65-8E53-218A3236784AQ41332742-3BCC04C9-6467-4D09-ABAC-7C9FE995DE5DQ41696499-A28DEBCA-5D0D-4E99-86E9-4B9CD36B1CB0Q44663610-B5209E85-426F-483A-9E29-0A6EFB98734BQ47713917-BDF40801-917C-4ADB-B826-B9A89C2CEBE3
P2860
Presymptomatic testing for neurogenetic diseases in Brazil: assessing who seeks and who follows through with testing.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Presymptomatic testing for neu ...... follows through with testing.
@en
Presymptomatic testing for neu ...... follows through with testing.
@nl
type
label
Presymptomatic testing for neu ...... follows through with testing.
@en
Presymptomatic testing for neu ...... follows through with testing.
@nl
prefLabel
Presymptomatic testing for neu ...... follows through with testing.
@en
Presymptomatic testing for neu ...... follows through with testing.
@nl
P2093
P2860
P1476
Presymptomatic testing for neu ...... follows through with testing.
@en
P2093
Caroline Santa Maria Rodrigues
Claudio Maria da Silva Osório
Gabriela Camargo
Laura Bannach Jardim
Raphael Machado de Castilhos
Viviane Ziebell de Oliveira
P2860
P304
P356
10.1007/S10897-011-9383-8
P577
2011-06-30T00:00:00Z